Research and development

Investing in

More than 2300 independent, peer-reviewed research papers have now been published on the bioactive properties of fucoidans. This extensive body of evidence includes comprehensive in vitro investigations, animal studies and human clinical trials. The vast majority of this research has been conducted in the last 20 years, with Marinova leading the way.

With state-of-the-art laboratories and a team of distinguished scientists, Marinova continues to develop novel fucoidan extracts with enhanced bioactivity. An extensive range of assays, commercial scale-up and quality testing are all undertaken in-house. In addition to the company’s own expertise, Marinova has an established global research network and collaborates with leading research institutions to undertake human clinical trials.

Fucorich®, sits alongside the portfolio of unique Maritech® organic fucoidan extracts. All of these products are the result of Marinova's active and ongoing research and development program that has spanned the course of two decades. Supported by state-of-the-art laboratories and a team of distinguished scientists, Marinova's organic fucoidans continue to be globally recognised for their quality and efficacy.